January 07, 2022
A California federal magistrate judge won't require Walgreens to disclose details of confidential settlements paid to former employees regarding the pharmacy giant's opioid dispensing practices, saying during a discovery hearing Friday that settlement amounts don't bolster claims that Walgreens and others fueled the opioid epidemic in San Francisco.
January 03, 2022
Health care and life sciences litigation is already red hot as 2022 begins and appears all but certain to intensify throughout the year as the clock ticks on time-sensitive lawsuits, the U.S. Supreme Court nears the end of its current term and opioid cases generate more trials and fresh drama. Here, Law360 explores five key litigation areas to watch.
October 26, 2021
Scorched by cover-up claims in nationwide opioid litigation, Endo Pharmaceuticals is hoping for heroics from a Skadden squad that is belatedly revealing vast volumes of drug marketing records, a strategy that could simultaneously snuff out some discovery deficiencies and fuel new doubts about the drugmaker's initial transparency.
September 17, 2021
A flash flood of misconduct inquiries in opioid litigation across the country is rapidly engulfing Endo Pharmaceuticals and threatening to inflict considerable damage on the professional reputations of its Arnold & Porter attorneys, according to legal filings, court proceedings and interviews.
July 28, 2021
Endo Pharmaceuticals and its Arnold & Porter lawyers are making "incredibly belated" discovery disclosures in multidistrict opioid litigation after a severe punishment for discovery violations in a separate opioid case, and an explanation under oath is needed, an Illinois federal judge heard Wednesday.
May 28, 2021
With the coronavirus crisis cooling down, a pressure cooker of opioid litigation is heating up with long-awaited trials across the country. Here, Law360 maps out the hottest cases and spotlights must-know details in trials that are underway or imminent.
March 17, 2021
A California federal magistrate judge overseeing San Francisco's lawsuit against Purdue Pharma, Walgreens and others for their alleged role in fueling the opioid epidemic ordered the California Department of Justice on Wednesday to give Walgreens so-called de-identified data on pharmacies' dispensing practices from the state's prescription drug monitoring system database.
December 18, 2020
A California federal magistrate judge overseeing the state's opioid epidemic case against Purdue Pharma and other pharmaceutical giants indicated Friday that the COVID-19 spike may delay the trial, stressing the importance of proceeding humanely and not requiring lawyers to work 20-hour days during the country's biggest public health emergency.
November 12, 2020
Attorneys for California told a federal magistrate judge Thursday that the state is pursuing its opioid epidemic case against pharmaceutical giants, regardless of Purdue Pharma's proposed $8 billion settlement with the federal government, saying its public nuisance claims seek reimbursement for the ongoing costs of abating the opioid crisis.
October 01, 2020
A California federal judge on Wednesday trimmed federal racketeering claims against drug companies in the city of San Francisco's suit over the opioid crisis, finding that city property damage caused by people addicted to opioids was too far removed from the companies' alleged actions, but allowed the rest of the city's claims to go ahead.